Transplant International

Article	Citations
Management of post‐transplant diabetes: immunosuppression, early prevention, and novel antidiabetics	69
A systematic review and meta‐analyses of regional perfusion in donation after circulatory death solid organ transplantation	65
Consensus statement on normothermic regional perfusion in donation after circulatory death: Report from the European Society for Organ Transplantation’s Transplant Learning Journey	52
The impact of COVID‐19 on kidney transplantation and the kidney transplant recipient – One year into the pandemic	39
Liver transplantation versus liver resection for colorectal liver metastasis: a survival benefit analysis in patients stratified according to tumor burden score	32
SARS‐CoV‐2 vaccination in solid‐organ transplant recipients: What the clinician needs to know	32
Recovery of kidney function after AKI because of COVID‐19 in kidney transplant recipients	28
Stratifying the humoral risk of candidates to a solid organ transplantation: a proposal of the ENGAGE working group	27
Recurrence of primary sclerosing cholangitis after liver transplantation – analysing the European Liver Transplant Registry and beyond	26
eHealth in transplantation	26
Magnetic resonance imaging assessment of renal flow distribution patterns during ex vivo normothermic machine perfusion in porcine and human kidneys	25
Abstracts	24
Machine learning in liver transplantation: a tool for some unsolved questions?	23
COVID‐19 and education: restructuring after the pandemic	23
Organoid transplant approaches for the liver	22
Human liver stem cell‐derived extracellular vesicles reduce injury in a model of normothermic machine perfusion of rat livers previously exposed to a prolonged warm ischemia	22
Diagnostic value of donor‐derived cell‐free DNA to predict antibody‐mediated rejection in donor‐specific antibody‐positive renal allograft recipients	22
Exploring the causes of the high incidence of delayed graft function after kidney transplantation in Brazil: a multicenter study	21
Simultaneous liver kidney allocation policy and the Safety Net: an early examination of utilization and outcomes in the United States	19
Eosinophils in transbronchial biopsies: a predictor of chronic lung allograft dysfunction and reduced survival after lung transplantation — a retrospective single‐center cohort study	18
A retrospective single‐centre analysis of the oncological impact of LI‐RADS classification applied to Metroticket 2.0 calculator in liver transplantation: every nodule matters	18
Kidney transplant recipient perspectives on telehealth during the COVID‐19 pandemic	18
Successful pancreas allotransplantations after hypothermic machine perfusion in a novel diabetic porcine model: a controlled study	17
The effects of exercise training in adult solid organ transplant recipients: A systematic review and meta‐analysis	16
Undoubtedly, kidney transplant recipients have a higher mortality due to COVID‐19 disease compared to the general population	16

EBV‐specific cytotoxic T lymphocytes for refractory EBV‐associated post‐transplant lymphoproliferative disorder in solid organ transplant recipients: a systematic review	15
Disease‐specific waitlist outcomes in liver transplantation – a retrospective study	15
A 2020 Banff Antibody‐mediatedInjury Working Group examination of international practices for diagnosing antibody‐mediated rejection in kidney transplantation – a cohort study	15
Prognostic role of the Donor Risk Index, the Eurotransplant Donor Risk Index, and the Balance of Risk score on graft loss after liver transplantation	14
Cellular therapies in organ transplantation	14
Long‐term outcome after hand and forearm transplantation – a retrospective study	14
Treatment of relapse and survival outcomes after liver transplantation in patients with colorectal liver metastases	14
Early intestinal complications following pancreas transplantation: lessons learned from over 300 cases – a retrospective single‐center study	13
Successful 18‐h acellular extracorporeal perfusion and replantation of porcine limbs ‐ Histology versus nerve stimulation	13
Autologous regulatory T cells in clinical intraportal allogenic pancreatic islet transplantation	13
Clinical implementation of coronary computed tomography angiography for routine detection of cardiac allograft vasculopathy in heart transplant patients	13
Full‐left‐full‐right split liver transplantation for adult recipients: a systematic review and meta‐analysis	13
An analysis of the outcomes in living donor liver transplantation for pediatric malignant hepatic tumors using nationwide survey data in Japan	13
Safe use of right lobe living donor livers with moderate steatosis in adult‐to‐adult living donor liver transplantation: a retrospective study	13
Proteomic analysis of machine perfusion solution from brain dead donor kidneys reveals that elevated complement, cytoskeleton and lipid metabolism proteins are associated with 1‐year outcome	13
Trends in indications and outcomes of liver transplantation in Canada: A multicenter retrospective study	13
Considering extended right lobe grafts as major extended donor criteria in liver transplantation is justified	12
Solid organ transplantation is not a risk factor for COVID‐19 disease outcome	12
ABO‐incompatible kidney transplantation in perspective of deceased donor transplantation and induction strategies: a propensity‐matched analysis	12
Glucagon‐like peptide‐1 receptor agonists and sodium‐glucose cotransporter 2 inhibitors for diabetes after solid organ transplantation	12
Short recipient warm ischemia time improves outcomes in deceased donor liver transplantation	12
Clinical value and limitations of the preoperative C‐reactive‐protein‐to‐albumin ratio in predicting post‐operative morbidity and mortality after deceased‐donor liver transplantation: a retrospective	11
Have we reached the limits in altruistic kidney donation?	11
The evolution of histological changes suggestive of antibody‐mediated injury, in the presence and absence of donor‐specific anti‐HLA antibodies	11
Assessment of the global practice of living donor liver transplantation	11
Decreased incidence of acute rejection without increased incidence of cytomegalovirus (CMV) infection in kidney transplant recipients receiving rabbit anti‐thymocyte globulin without CMV prophylaxis –	11
Number of hepatocellular carcinoma nodules in patients listed for liver transplantation within alpha‐fetoprotein score: a new prognostic risk factor	11
Organ transplants of the future: planning for innovations including xenotransplantation	11
Hypothermic oxygenated machine perfusion of the human pancreas for clinical islet isolation: a prospective feasibility study	11
The impact of functional delayed graft function in the modern era of kidney transplantation – A retrospective study	11
Development of ex situ normothermic reperfusion as an innovative method to assess pancreases after preservation	11
A systematic review and meta‐analysis on the incidence of osteoporosis and fractures after liver transplant	11
Successful liver transplantation immediately after recovery from COVID‐19 in a highly endemic area	11
Center volume and primary graft dysfunction in patients undergoing lung transplantation in the United States – a cohort study	11
Managing immunosuppressive therapy in potentially cured post‐kidney transplant cancer (excluding non‐melanoma skin cancer): an overview of the available evidence and guidance for shared decision‐makin	11
Guiding therapeutic plasma exchange for antibody‐mediated rejection treatment in lung transplant recipients – a retrospective study	10
Impact of coronavirus disease 2019 on organ donation and transplantation in France	10
Mini‐organs forum: how to advance organoid technology to organ transplant community	10
Bisphosphonate therapy after liver transplant improves bone mineral density and reduces fracture rates: an updated systematic review and meta‐analysis	10
Health‐related quality of life, uncertainty and coping strategies in solid organ transplant recipients during shielding for the COVID‐19 pandemic	10
Addressing ethical confusion in deceased donation and transplantation research: the need for dedicated guidance	10
Impact of unilateral diaphragm elevation on postoperative outcomes in bilateral lung transplantation – a retrospective single‐center study	10
Delayed introduction of sirolimus in paediatric intestinal transplant recipients: indications and long‐term benefits	10
Non‐simultaneous kidney exchange cycles in resource‐restricted countries without non‐directed donation – a prospective single‐center cohort study	10
COVID‐19 among kidney‐transplant recipients requiring hospitalization: preliminary data and outcomes from a single‐center in Brazil	10
Cell therapy during machine perfusion	10
Deciphering transplant outcomes of expanded kidney allografts donated after controlled circulatory death in the current transplant era. A call for caution	10
Influence of donor‐transmitted coronary artery disease on long‐term outcomes after heart transplantation ‐ a retrospective study	10
Editorial: changing of the guard at Transplant International	10
US food and drug administration (FDA) panel endorses islet cell treatment for type 1 diabetes: A pyrrhic victory?	10

Intravenous immunoglobulins do not prove beneficial to reduce alloimmunity among kidney transplant recipients with BKV‐associated nephropathy	10
COVID‐19 in lung transplant recipients: an overview of the Swedish national experience	10
Pre‐transplant donor‐specific HLA antibodies and risk for poor first‐year renal transplant outcomes: results from the Swiss Transplant Cohort Study	9
Efficacy and safety of conventional antiviral agents in preventive strategies for cytomegalovirus infection after kidney transplantation: a systematic review and network meta‐analysis	9
Anti‐HLA and anti‐SARS‐CoV‐2 antibodies in kidney transplant recipients with COVID‐19	9
Pancreas utilization rates in the UK – an 11‐year analysis	9
Safety and efficacy of direct oral anticoagulants under long‐term immunosuppressive therapy after liver, kidney and pancreas transplantation	9
Safety of intra‐operative blood salvage during liver transplantation in patients with hepatocellular carcinoma, a propensity score‐matched survival analysis	9
Conditional probability of graft survival in liver transplantation using donation after circulatory death grafts – a retrospective study	9
Graft utilization after normothermic regional perfusion in controlled donation after circulatory death—a single‐center perspective from France	9
The Liver Retransplantation Risk Score: a prognostic model for survival after adult liver retransplantation	9
Application of ischaemia‐free liver transplantation improves prognosis of patients with steatotic donor livers – a retrospective study	9
Short‐ and long‐term results of liver transplantation according to age at transplant: a single‐center experience of 351 children	9
Clinical manifestations and outcomes of coronavirus disease‐19 in heart transplant recipients: a multicentre case series with a systematic review and meta‐analysis	9
Malignancy following heart transplantation: differences in incidence and prognosis between sexes – a multicenter cohort study	8
Portal vein thrombosis and renal dysfunction: a national comparative study of liver transplant recipients for NAFLD versus alcoholic cirrhosis	8
Advanced donor age does not increase risk of hepatocellular carcinoma recurrence after liver transplantation: a retrospective two‐centre analysis using competing risk analysis	8
Liver transplantation for congenital hepatic fibrosis	8
Association between procurement biopsy findings and deceased donor kidney outcomes: a paired kidney analysis	8
Assessment of the Banff Working Group classification of definitive BK polyomavirus nephropathy	8
The real incidence of biliary tract complications after adult liver transplantation: the role of the prospective routine use of cholangiography during post‐transplant follow‐up	8
Metabolic outcomes and renal function after simultaneous kidney/pancreas transplantation compared with kidney transplantation alone for type 2 diabetes mellitus patients	8
Cancer transmissions and non‐transmissions from solid organ transplantation in an Australian cohort of deceased and living organ donors	8
Lung transplantation from uncontrolled and controlled donation after circulatory death: similar outcomes to brain death donors	8
Correcting anemia and native vitamin D supplementation in kidney transplant recipients: a multicenter, 2 × 2 factorial, open‐label, randomized clinical trial	8
Outcomes with alemtuzumab induction therapy in lung transplantation: a comprehensive large‐scale single‐center analysis	8
Sequential genetic testing of living‐related donors for inherited renal disease to promote informed choice and enhance safety of living donation	8
Personalized physical rehabilitation program and employment in kidney transplant recipients: a randomized trial	7
Prolonged immunosuppression does not improve risk of sensitization or likelihood of retransplantation after kidney transplant graft failure	7
Cost analysis of a long‐term randomized controlled study in biliary duct‐to‐duct anastomotic stricture after liver transplantation	7
Outcome of kidney transplantation from very senior donors in Switzerland – a national cohort study	7
Implementation of the kidney team at home intervention: Evaluating generalizability, implementation process, and effects	7
Improving the predictability of time to death in controlled donation after circulatory death lung donors	7
Kidney transplantation and patients who decline SARS‐CoV‐2 vaccination: an ethical framework	7
Anti‐interleukin‐6 antibody clazakizumab in late antibody‐mediated kidney transplant rejection: effect on cytochrome P450 drug metabolism	7
What happens after graft loss? A large, long‐term, single‐center observation	7
Long‐term kidney function and survival in recipients of allografts from living kidney donors with hypertension: a national cohort study	7
Complications of polytetrafluoroethylene graft use in middle hepatic vein reconstruction in living donor liver transplantation: a retrospective, single‐centre, long‐term, real‐world experience	7
Pulmonary infections after renal transplantation: a prospective study from a tropical country	7
Management of early hepatic artery thrombosis following living‐donor liver transplantation: feasibility, efficacy and potential risks of endovascular therapy in the first 48 hours post‐transplant–a re	6
COVID‐19 in solid organ transplantation: an analysis of the impact on transplant activity and wait lists	6
Significance of phenotype change after chronic lung allograft dysfunction onset	6
Extraperitoneal kidney transplantation: a comparison between children weighting ≤15 kg and >15 kg. Experience of a single institution	6
Changing patterns of clinical decision making: are falling numbers of antibody incompatible transplants related to the increasing success of the UK Living Kidney Sharing Scheme? A national cohort stud	6
Allograft nephrectomy versus nonallograft nephrectomy after failed renal transplantation: a systematic review by updated meta‐analysis	6
Donor diabetes mellitus is a risk factor for diminished outcome after liver transplantation: a nationwide retrospective cohort study	6
A challenging liver transplantation for decompensated alcoholic liver disease after recovery from SARS‐CoV‐2 infection	6
A meta‐analysis of the cumulative incidence, risk factors, and clinical outcomes associated with chronic kidney disease after liver transplantation	6
Venous outflow congestion is related to poor recurrence‐free survival of living donor liver transplantation recipients with hepatocellular carcinoma – a retrospective study	6
Short versus prolonged antibiotic treatment for complicated urinary tract infection after kidney transplantation	6
Critical pathway for deceased tissue donation: a novel adaptative European systematic approach	6
The tacrolimus metabolism affect post‐transplant outcome mediating acute rejection and delayed graft function: analysis from Korean Organ Transplantation Registry data	6
Temporal trends and impact of willingness to accept organs from donors with hepatitis C virus	6
Observational study of risk factors associated with clinical outcome among elderly kidney transplant recipients in Sweden – a decade of follow‐up	6
Extreme hyponatremia as a risk factor for early mortality after liver transplantation in the MELD‐sodium era	6
Is simplification of immunosuppressive medication a way to promote medication adherence of kidney transplant recipients? Findings from a randomized controlled trial	5
Post‐kidney transplant serum magnesium exhibits a U‐shaped association with subsequent mortality: an observational cohort study	5
Pretransplantation splenomegaly frequently persists after liver transplantation and can manifest as hypersplenism and graft fibrosis ‐ a retrospective study	5
Small donors for small recipients – excellent growth and long‐term function of single kidney grafts	5
High trough levels of everolimus combined to sorafenib improve patients survival after hepatocellular carcinoma recurrence in liver transplant recipients	5
Impact of changing renal function, while waiting for a heart transplant, on post‐transplant mortality and development of end stage kidney disease	5
Hepatocellular carcinoma and the risk of de novo malignancies after liver transplantation – a multicenter cohort study	5
Kidney paired donation in Brazil – a single center perspective	5
Successful surgical weight loss with laparoscopic sleeve gastrectomy for morbid obesity prior to kidney transplantation	5
Liver transplantation versus watchful waiting in hepatocellular carcinoma patients with complete response to bridging therapy – a retrospective observational study	5
Two‐year protocol biopsy after kidney transplantation in clinically stable recipients – a retrospective study	5
Short‐ and long‐term impact of neutropenia within the first year after kidney transplantation	5
Anticoagulation practices in total pancreatectomy with autologous islet cell transplant patients: an international survey of clinical programs	5
Usefulness of an organ donation opinion survey as a tool to promote organ donation among the adolescent population	5
Endogenous memory T cells with donor‐reactivity: early post‐transplant mediators of acute graft injury in unsensitized recipients	5
Access of non‐residents to transplantation of deceased donor organs: practices and strategies in the European setting	5
Early detection of SARS‐CoV‐2 and other infections in solid organ transplant recipients and household members using wearable devices	5
Bone densitometry versus bone histomorphometry in renal transplanted patients: a cross‐sectional study	5
A meta‐analysis on the incidence of donor‐related depression after liver transplant	5
Comparison of pregnancy outcomes in Dutch kidney recipients with and without calcineurin inhibitor exposure: a retrospective study	5
The effect of organ preservation solutions on short‐term outcomes after liver transplantation: a single‐center retrospective study	5
Early perioperative fluid overload is associated with adverse outcomes in deceased donor kidney transplantation	5
The prognostic significance of serum aspartate transaminase and gamma‐glutamyl transferase in liver deceased donors	5
Seasonal trends in donor heart availability: an analysis of the UNOS database	5
Risk factors for Epstein–Barr virus reactivation after renal transplantation: Results of a large, multi‐centre study	5

Hand‐assisted retroperitoneoscopic donor nephrectomy offers more liberal use of right kidneys: lessons learned from 565 cases – a retrospective single‐center study	5
Diagnostic and therapeutic management algorithm for biliary complications in living liver donors	5
Living well with kidney disease by patient and care partner empowerment: kidney health for everyone everywhere	5
Increased rejection rates in kidney transplantations during the COVID‐19 pandemic	5
Donor age (≥45 years) and reduced immunosuppression are associated with the recurrent primary sclerosing cholangitis after liver transplantation – a multicenter retrospective study	4
Impacts of single nucleotide polymorphisms in Fc gamma receptor IIA ( rs1801274 ) on lung transplant outcomes among Japanese lung transplant recipients	4
Predicting recurrence of hepatocellular carcinoma after liver transplantation using a novel model that incorporates tumor and donor‐related factors	4
Solid organ transplantation during the COVID‐19 pandemic in the United States	4
The COVID‐19 second wave risk and liver transplantation: lesson from the recent past and the unavoidable need of living donors	4
Elevated serum sodium in recipients of liver transplantation has a substantial impact on outcomes	4
Liver transplantation for hepatocellular carcinoma: impact of expansion criteria in a multicenter cohort study from a high waitlist mortality region	4
The relationship between proteinuria and allograft survival in patients with transplant glomerulopathy: a retrospective single‐center cohort study	4
Successful treatment of acute kidney allograft rejection using extracorporeal photopheresis in the context of post‐transplant lymphoproliferative diseases: three successive cases	4
Fatty liver disease in living liver donors: a single‐institute experience of 220 donors	4
Solid organ donor–recipient race‐matching: analysis of the United Network for Organ Sharing database	4
Recipient age and outcome after pancreas transplantation: a retrospective dual‐center analysis	4
The adapted Heart Donor Score	4
MiR‐339 and galectin‐3: diagnostic value in patients with airway obstruction after lung transplantation	4
Biomarkers as diagnostic tests for delayed graft function in kidney transplantation	4
A meta‐analysis on the prevalence of chronic kidney disease in liver transplant candidates and its associated risk factors and outcomes	4
Comparative survival of elderly renal transplant recipients with a living donor versus a deceased donor: A retrospective single center observational study	4